Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eyevensys S.A.S.
DescriptionDNA plasmid encoding a therapeutic protein combined with an injection-electroporation device
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPreclinical
Standard IndicationUveitis
Indication DetailsTreat non-infectious posterior uveitis; Treat refractory non-infectious uveitis
Regulatory Designation EU - Orphan Drug (Treat refractory non-infectious uveitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today